Vivo Capital, LLC Portfolio Holdings

Vivo Capital, LLC

  • $368 Million
  • Q1 2025

Vivo Capital, LLC has filed its 13F form on May 12, 2025 for Q1 2025 where it was disclosed a total value porftolio of $368 Million distributed in 40 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $91.3M, Geron Corp with a value of $43.3M, Compass Pathways PLC with a value of $28.7M, Trevi Therapeutics, Inc. with a value of $21.9M, and Terns Pharmaceuticals, Inc. with a value of $19M.

Examining the 13F form we can see an decrease of $144M in the current position value, from $512M to 368M.

Vivo Capital, LLC is based out at Palo Alto, CA

Below you can find more details about Vivo Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $368 Million
Healthcare: $368 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$35M
$8.77 Million 2.38% of portfolio
1,842,751
Q2 2024 New
$42.9M
$6.73 Million 1.83% of portfolio
6,173,439
Q3 2023 Added 104.72%
$28M
$176,000 0.05% of portfolio
765,500
Q1 2025 Reduced 74.1%

Summary

  • Portfolio
  • No. of Stocks 40
  • Current Value $368 Million
  • Prior Value $512 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 12, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 3 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email